Approaching the subject from a clinical standpoint, investigating the influence of PDL1 on patient survival in specific cancer subtypes provides profound insights into the mechanisms of tumor immune evasion and facilitates the development of personalized treatment strategies. The gene discussed is CD274; the disease is cancer.